Clinical Trial Update: Study In Women And Men With Metastatic Breast Cancer That Have Overexpression Of ErbB2 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for metastatic breast cancer with ErbB2 overexpression; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Neoplasms of Breast

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Neoplasms, Breast | Phase 3 | Status: COMPLETED | Results posted: 2011-06-01